A61L2103/05

Collagen-based meniscus implants

A method for producing a collagen meniscus implant by obtaining a freshly excised non-human meniscus, rinsing it in an aqueous solution, drying the rinsed meniscus, shaping it to approximate in dimension an average-sized human meniscus, extracting non-collagenous material from the shaped meniscus, and sterilizing it, yielding a collagen meniscus implant containing at least 90% by weight of type I collagen, less than 0.5% by weight of glycosaminoglycan, and less than 600 ppm DNA. Also disclosed is a collagen meniscus implant prepared by the above method. Further provided is a biocompatible and bioresorbable porous implant for meniscus repair. The implant includes a three-dimensional network of collagen fibers oriented in a direction approximating the collagen fiber orientation of a human meniscus. The implant has a size and a contour substantially equivalent to a human meniscus, and has a chemical composition similar to the above-described collagen meniscus implant.

INACTIVATION APPARATUS
20260027246 · 2026-01-29 · ·

The inactivation apparatus includes: an excimer lamp that includes a luminous tube, and a pair of electrodes, and generates ultraviolet light having a main emission wavelength band within a range of 190 nm or more and less than 240 nm in the luminous tube when a voltage is applied between the pair of electrodes; and an optical filter into which ultraviolet light generated by the excimer lamp is incident, the optical filter transmitting ultraviolet light having a wavelength within a range of 190 nm or more and less than 240 nm and substantially not transmitting ultraviolet light having a wavelength within a range of 240 nm or more and less than 280 nm, in which a sealing pressure ratio of the halogen gas to the noble gas in the luminous gas sealed in the luminous tube is 2% or more and less than 5%.

ODOR ELIMINATING COMPOSITION
20260053726 · 2026-02-26 ·

A composition for eliminating the odor of animal secretions of sprayed animals and articles can, in one embodiment, include garlic oil and reduced glutathione. A method and kit for eliminating the odor of animal secretions of sprayed animals and articles using the odor eliminating composition can optionally include 13% w/v to 25% w/v one or more of a surfactant, 1% w/v to 11% w/v one or more of an emulsifier, 1.0% w/v to 5.0% w/v one or more of a humectant, 1.0% w/v 10.0% w/v one or more of an oil, 1.0% w/v to 6.0% w/v one or more of a preservative, 0.1% w/v to 5.0% w/v one or more of an antioxidant, 0.1% w/v to 1.5% w/v one or more of a pH stabilizer, and 40% w/v to 85% w/v one or more of a solvent.

Preparation for removal and/or prevention of an infection associated with <i>Staphylococcus epidermidis</i>

Described is a method for treating or preventing an infection, such as an infection associated with Staphylococcus epidermidis such as a Health-Care Associated infection, a wound, a sore, an ulcer, a burn. The method includes applying a treatment preparation to a treatment site, the treatment preparation has a first component having a single amino acid, said single amino acid being leucine, and a second component having an active chlorine compound.

Electronic sanitizing devices and methods
12558444 · 2026-02-24 · ·

An electronic sanitizing device includes a germicidal light source and one or both of a red light source or a near infrared light source. The germicidal light source is configured to output germicidal light with a peak wavelength of 250 to 270 nanometers. The red light source is configured to output red light with a peak wavelength of 620 to 700 nanometers. The near infrared light source is configured to output near infrared light with a peak wavelength of 800 to 1200 nanometers.

SYSTEM AND METHODS FOR IMPLEMENTING A BIOLOGICAL FLUID TREATMENT DEVICE
20260048161 · 2026-02-19 ·

Electronic devices for treating a biological fluid and methods of operating the devices are disclosed. In some embodiments, the electronic device includes a plurality of non-safety critical components, a first controller communicatively coupled to the plurality of non-safety critical components, a plurality of safety critical components, and a second controller communicatively coupled to the plurality of safety critical components. In some embodiments, the electronic device includes a treatment interface.

STERILIZATION MODULE

An embodiment of the present disclosure relates to a sterilization module comprising: a light source module that generates light; a light guide which extends in a first direction and into which the light is incident; and a body having an upper surface that is open and supporting the light guide disposed therein, wherein the light guide includes a first side and a second side disposed opposite the first side in the first direction, and the light source module is disposed on the first side of the light guide to allow the light to be incident on the light guide.

UV APPLICATION ENHANCEMENTS FOR IN OR ON-BODY PATHOGEN ERADICATION
20260048275 · 2026-02-19 ·

An endoscope having a UV light emitting LED on a distal end of its insertion tube for pathogen eradication within a body or object or a UV emitting light source in the handle of the endoscope optically connected to a transmission fiber extending to the distal end. Devices for maintaining uniform power of UV light on a pathogen containing site of either a spacer for direct constant contact or a distance sensor which correspondingly changes output power for uniform power impingement. A bandage-like device for disinfection having UV transmitting fibers or UV emitting LEDs placed in close proximity to a wound or infected body site, for effecting disinfection and maintaining sterility against infective pathogens. A device with confined heat generating UV light emitting LED having a pulse generator for reducing heat while maintaining pathogen eradication. A hollow core fiber optically connected to a UV pulse laser which is resistant to degradation at the connection.

Isoproterenol compositions and methods

Storage stable aqueous ready-to-administer formulations comprising isoproterenol are presented with desirable stability characteristics. In preferred aspects, formulations are terminally sterilized and packaged in a suitable format, such as a polymeric bag with metalized overwrap and include a non-contact oxygen scavenger.

Apparatus, method and system for selectively affecting and/or killing a virus

Certain exemplary embodiments of the present disclosure can provide an apparatus and method for generating at least one radiation can be provided. The exemplary apparatus and/or method can selectively kill and/or affect at least one virus. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 200 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range can be provided or which can be substantially harmful to cells of the body.